| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0003319714568516 |
| P698 | PubMed publication ID | 25616679 |
| P2093 | author name string | Yong Liu | |
| Wei Guo | |||
| Ning Tan | |||
| Chong-Yang Duan | |||
| Ji-Yan Chen | |||
| Hua-Long Li | |||
| Shi-Qun Chen | |||
| Yuan-Hui Liu | |||
| P2860 | cites work | Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study | Q45310759 |
| Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells | Q46776017 | ||
| Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED. | Q46798469 | ||
| Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system | Q46809905 | ||
| Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease | Q46885356 | ||
| Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. | Q51299964 | ||
| Hyperuricemia is an independent risk factor for mortality only if chronic kidney disease is present. | Q54453260 | ||
| Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged Men | Q57303589 | ||
| Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study | Q57740599 | ||
| Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. | Q30336517 | ||
| Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data | Q33784030 | ||
| Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider | Q33969455 | ||
| Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi | Q34272627 | ||
| Epidemiology and prognostic implications of contrast-induced nephropathy | Q34570528 | ||
| Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease | Q34724943 | ||
| The relationship between hyperuricemia and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with relatively normal serum creatinine | Q36554964 | ||
| Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro | Q36899445 | ||
| Contrast-induced nephropathy: what are the true clinical consequences? | Q37051997 | ||
| Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study. | Q39665068 | ||
| Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. | Q42170160 | ||
| Hyperuricemia induces endothelial dysfunction | Q42477084 | ||
| Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress | Q42829265 | ||
| Hyperuricemia exacerbates chronic cyclosporine nephropathy. | Q43605144 | ||
| Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects | Q43840677 | ||
| Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. | Q43984512 | ||
| Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. | Q44438488 | ||
| The association of serum uric acid levels with outcomes following percutaneous coronary intervention | Q44949786 | ||
| P433 | issue | 8 | |
| P921 | main subject | acute kidney injury | Q424337 |
| P304 | page(s) | 721-726 | |
| P577 | publication date | 2015-01-23 | |
| P1433 | published in | Angiology | Q4763277 |
| P1476 | title | Hyperuricemia Is an Independent Predictor of Contrast-Induced Acute Kidney Injury and Mortality in Patients Undergoing Percutaneous Coronary Intervention | |
| P478 | volume | 66 |
| Q42334071 | Are There Modifiable Risk Factors to Improve AKI? |
| Q90074547 | Artificial Intelligence in Acute Kidney Injury Risk Prediction |
| Q36941514 | Association between previous history of gout attack and risk of deep vein thrombosis - a nationwide population-based cohort study |
| Q45025526 | Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases |
| Q92593555 | Hyperuricemia and long-term mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention |
| Q36251821 | Hyperuricemia increases the risk of acute kidney injury: a systematic review and meta-analysis. |
| Q51344476 | Preprocedural High-Sensitivity C-Reactive Protein Predicts Contrast-Induced Nephropathy and Long-Term Outcome After Coronary Angiography. |
| Q49055057 | Serum Uric Acid and Risk for Acute Kidney Injury Following Contrast |
| Q53806301 | [Relationship between hyperuricemia and adverse events in patients aged 40 years or older receiving rheumatic aortic valve replacement]. |
Search more.